| 期 |
标题 |
文件 |
| 卷 7, 编号 2 (2010) |
Optimizatsiya antigipertenzivnoy terapii u bol'nykh arterial'noy gipertoniey vysokogo riska: novaya rossiyskaya programma STRATEGIYa A.(roSsiyskaya mnogotsenTrovaya pRogrammA po otsenke effekTivnosti noliprEla A forte u patsientov s arterial'noy GIpertoniey vysokogo riska s nedostatochnym kontrolem arterial'nogo davleniYa) |
|
|
Chazova I., Martynyuk T.
|
| 卷 8, 编号 3 (2011) |
Optimizatsiya antigipertenzivnoyterapii u patsientov s khronicheskoyserdechnoy nedostatochnost'yuI-II funktsional'nykh klassov |
|
|
Kanorskiy S., Tregubov V., Pokrovskiy V.
|
| 卷 11, 编号 1 (2014) |
Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors |
(Rus)
|
|
Trukhan D., Tarasova L.
|
| 卷 9, 编号 1 (2012) |
Optimizatsiya lecheniya ishemicheskoy bolezni serdtsa i arterial'noy gipertonii pri primenenii zofenoprila |
|
|
Evdokimova A., Evdokimov V., Smetanin A., Leonenko N., Churkina N.
|
| 卷 2, 编号 2 (2005) |
Optimizatsiya lecheniya patsientov s sochetannymi formami arterial'noy gipertonii i ishemicheskoy bolezni serdtsa |
|
|
Volkova E.
|
| 卷 16, 编号 3 (2019) |
Experience of the management of patients with pulmonary hypertension in the Republic of Karelia |
(Rus)
|
|
Ryabkov V., Vezikova N., Malygin A., Novozhilova N., Merenkov V.
|
| 卷 11, 编号 1 (2014) |
Experience of treating hypertension in an outpatient setting: a clinical case |
(Rus)
|
|
Agafonov A., Khozyainova N., Petruschenkova O.
|
| 卷 15, 编号 1 (2018) |
Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2 |
(Rus)
|
|
Statsenko M., Turkina S., Titarenko M.
|
| 卷 17, 编号 3 (2020) |
Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II |
(Rus)
|
|
Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Khaisheva L., Kameneva T.
|
| 卷 5, 编号 3 (2008) |
Organoprotektivnye effekty zofenoprila u bol'nykh s arterial'noy gipertoniey |
|
|
Evdokimova A., Ol'khin V., Leonenko N.
|
| 卷 9, 编号 4 (2012) |
Organ-protective effect of fixed-dose combination antihypertensive therapy with eprosartan and hydrochlorothiazide for subclinical and clinical target organ damage in hypertensive patients |
|
|
Koziolova N., Bushmakina A., Kovalevskaya N., Shatunova I.
|
| 卷 16, 编号 2 (2019) |
Orthostatic reactions and cognitive dysfunctions in elderly and senile patients with arterial hypertension |
(Rus)
|
|
Atyunina I., Oschepkova E., Rogoza A., Lazareva N.
|
| 卷 2, 编号 2 (2005) |
Osnovnye rezul'taty programmy APREL' |
|
|
Chazova I., Mychka V., Belenkov Y.
|
| 卷 9, 编号 1 (2012) |
Osnovy optimal'nogo vybora sredi vzaimozamenyaemykh lekarstvennykh sredstv pri lechenii serdechno-sosudistykh zabolevaniy |
|
|
Chernyavskaya T.
|
| 卷 15, 编号 4 (2018) |
Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes |
(Rus)
|
|
Kovalenko F., Skibitsky V., Fendrikova A.
|
| 卷 16, 编号 3 (2019) |
Features of arterial hypertension patients with discrepancies in vectorcardiographic and echocardiographic conclusions about the presence of left ventricular hypertrophy [Original Article] |
(Rus)
|
|
Blinova E., Sakhnova T., Chaykovskaya O., Saidova M., Ryabykina G.
|
| 卷 11, 编号 4 (2014) |
Peculiarity of medical management of patients with arterial hypertension after liver transplantation |
(Rus)
|
|
Kosmacheva Y., Babich A.
|
| 卷 9, 编号 2 (2012) |
Osobennosti vodno-elektrolitnogo obmena u bol'nykh arterial'noy gipertoniey i vliyanie na ego parametry razlichnykh klassov gipotenzivnykh preparatov |
|
|
Samerkhanova L., Luk'yanov M., Masenko V., Boytsov S.
|
| 卷 18, 编号 3 (2021) |
Clinical features and course of arterial hypertension in patients with its various forms |
(Rus)
|
|
Denisova A., Esaulova T., Solntseva T., Sivakova O., Chazova I.
|
| 卷 11, 编号 1 (2014) |
Hypertension treatment features in perimenopausal women |
(Rus)
|
|
Zhernakova Y., Chazova I.
|
| 卷 13, 编号 3 (2016) |
Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology |
(Rus)
|
|
Dolgova E., Fedorovich A., Martynyuk T., Rogoza A., Chazova I.
|
| 卷 9, 编号 1 (2012) |
Osobennosti patogeneza arterial'noy gipertenzii u bol'nykh s metabolicheskim sindromom |
|
|
Krasil'nikova E., Baranova E., Blagosklonnaya Y.
|
| 卷 14, 编号 4 (2017) |
Features of the use of torasemide in arterial hypertension |
(Rus)
|
|
Baryshnikova G., Chorbinskajya S.
|
| 卷 13, 编号 2 (2016) |
Features of cardiac remodeling in patients with hypertension of different ethnic groups |
(Rus)
|
|
Abramov E., Nevzorova V., Repina N.
|
| 卷 15, 编号 3 (2018) |
Features of diurnal blood pressure profile, arterial stiffness and left ventricular structure and function in patients with arterial hypertension, prediabetes and type 2 diabetes mellitus |
(Rus)
|
|
Fendrikova A., Gutova S., Skibitsky V., Skibitsky A.
|
| 卷 10, 编号 3 (2013) |
Osobennosti techeniya serdechno-sosudistykh zabolevaniy i printsipy vybora ratsional'noy antigipertenzivnoy terapii u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh |
|
|
Napalkov D., Panferov A.
|
| 卷 9, 编号 3 (2012) |
Osobennosti faktorov riska, mekhanizmov razvitiya, klinicheskogo techeniya i porazheniya organov-misheney u bol'nykh arterial'noy gipertenziey molodogo vozrasta |
|
|
Chernova I., Luk'yanov M., Serdyuk S., Boytsov S.
|
| 卷 17, 编号 2 (2020) |
Features of cerebral autoregulation and reactivity in patients with arterial hypertension in older age groups with orthostatic hypotensive reactions |
(Rus)
|
|
Atyunina I., Oshchepkova E., Rogoza A.
|
| 卷 9, 编号 4 (2012) |
Electrical and viscoelastic parameters of erythrocytes in patients with different degrees of arterial hypertension |
|
|
Gromov A., Kruchinina M., Rabko A., Baum V., Generalov V.
|
| 卷 16, 编号 2 (2019) |
Acute heart failure and microRNA |
(Rus)
|
|
Nasonova S., Mindzaev D., Zhirov I., Tereshchenko S.
|
| 卷 12, 编号 4 (2015) |
From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift |
(Rus)
|
|
Ostroumova O., Bondarets O., Kopchenov I., Guseva T.
|
| 卷 1, 编号 2 (2004) |
Ot idei k klinicheskoy praktike: pervye rezul'taty Rossiyskogo natsional'nogo issledovaniya optimal'nogo snizheniya arterial'nogo davleniya (ROSA) |
|
|
Chazova I., Belenkov Y.
|
| 卷 16, 编号 4 (2019) |
Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension |
(Rus)
|
|
Karabasheva M., Danilov N., Sagaidak O., Matchin Y., Chazova I.
|
| 卷 11, 编号 2 (2014) |
National questionnaire of treatment compliance:testing and application in outpatient practice |
(Rus)
|
|
Fofanova T., Ageev F., Smirnova M., Svirida O., Kuzmina A., Thostov A., Nelyubina A.
|
| 卷 7, 编号 4 (2010) |
Otkrytoe randomizirovannoe mnogotsentrovoe sravnitel'noe issledovanie effektivnosti i bezopasnosti preparatov Al'betor®i enalaprilat u bol'nykh s neoslozhnennym gipertonicheskim krizom (AL'BATROS). |
|
|
Tereshchenko S., Abdrakhmanov V., Gaponova N., Uskach T., Kostsina I., Skibitskiy V., Kobalava Z., Bagmanova N., Grinshteyn Y., Shabalin V., Pletneva L., Lopatin Y., Karpov A., Mordovin V., Tsymbalyuk E., Shutemova E., Kiselev A.
|
| 卷 10, 编号 1 (2013) |
Evaluation of the antihypertensive efficacy and safety of moxonidine in the treatment of uncomplicated hypertensive crisis |
|
|
Tereshchenko S., Gaponova N., Abdrakhmanov V.
|
| 卷 8, 编号 4 (2011) |
Otsenka antigipertenzivnoy effektivnosti i bezopasnosti moksonidina pri lechenii neoslozhnennogo gipertonicheskogo kriza |
|
|
Tereshchenko S., Gaponova N., Abdrakhmanov V.
|
| 卷 18, 编号 3 (2021) |
Evaluation of heart rate variability in patients with different forms of pulmonary hypertension |
(Rus)
|
|
Qurbonbekova N., Kasparova A., Kozhemyakina E., Sobolev A., Martynyuk T.
|
| 卷 17, 编号 4 (2020) |
Impact of metabolic syndrome parameters and different fat depots on arterial stiffness in patients with abdominal obesity |
(Rus)
|
|
Andreevskaia M., Zheleznova E., Zhernakova J., Chazova I., Shariia M., Blinova N., Zairova A., Azimova M., Rogoza A., Saidova M.
|
| 卷 14, 编号 2 (2017) |
Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine |
(Rus)
|
|
Kuznetsova E., Glukhova S., Martynyuk T., Nakonechnikov S., Chazova I.
|
| 卷 14, 编号 2 (2017) |
Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data) |
(Rus)
|
|
Oshchepkova E., Lazareva N., Chazova I.
|
| 卷 16, 编号 2 (2019) |
Evaluation of compliance of pulmonary hypertension patients to the treatment with inhaled iloprost (Ventavis): results of prospective, multicenter, non-interventional IVENT study |
(Rus)
|
|
Martynyuk T.
|
| 卷 9, 编号 3 (2012) |
Otsenka simpaticheskoy aktivnosti dlya differentsirovannogo okazaniya neotlozhnoy pomoshchi pri povyshenii arterial'nogo davleniya |
|
|
Ruksin V., Grishin O., Golovkin N.
|
| 卷 15, 编号 4 (2018) |
Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy |
(Rus)
|
|
Avalyan A., Oshchepkova E., Saidova M., Shitov V., Glazkova E., Stenina M., Chazova I.
|
| 卷 17, 编号 4 (2020) |
Assessment of epicardial adipose tissue by echocardiography for risk stratification in young adults with abdominal obesity |
(Rus)
|
|
Blinova N., Azimova M., Zhernakova J., Saidova M., Ternovoy S., Zheleznova E., Azimova M., Chazova I.
|
| 卷 13, 编号 2 (2016) |
Evaluating of the effectiveness and safety of the reproduced selective β1-blocker without intrinsic sympathomimetic activity Bidop® in patients with hypertrophic cardiomyopathy |
(Rus)
|
|
Feiskhanova L., Malov A.
|
| 卷 15, 编号 4 (2018) |
Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension |
(Rus)
|
|
Arkhipova O., Gratsianskaya S., Martynyuk T.
|
| 卷 13, 编号 2 (2016) |
Assessment of efficiency and safety of application of the reproduced drug of Mertenil® according to MSCT-coronary angiography |
(Rus)
|
|
Malov A., Feiskhanova L.
|
| 卷 2, 编号 1 (2005) |
Otsenka effektivnosti moeksiprila u bol'nykh myagkoy i umerennoy arterial'noy gipertoniey s gipertrofiey miokarda levogo zheludochka (issledovanie ENIGMA) |
|
|
Belenkov Y., Chazova I., Ratova L., Ataullakhanova D., Karpov R., Shlyakhto E., Fomin I.
|
| 卷 11, 编号 2 (2014) |
Efficacy and safety of amlodipine and perindopril (Prestance) fixed combination in patients with arterial hypertension during the summer heat |
(Rus)
|
|
Chazova I., Ageev F., Smirnova M., Ageeva N., Fofanova T., Svirida O., Mikhailov G., Levin A., Revich B.
|
| 卷 12, 编号 3 (2015) |
Pathogenetic treatment of chronic heart failure: the role of torasemide |
(Rus)
|
|
Perepech N.
|
| 卷 8, 编号 4 (2011) |
Patsient vysokogo kardiovaskulyarnogo riska: ot organoprotektsii k uluchsheniyu prognoza |
|
|
Skibitskiy V.
|
| 卷 9, 编号 3 (2012) |
Patsient s arterial'noy gipertenziey i assotsiirovannymi klinicheskimi sostoyaniyami: voprosy lecheniya |
|
|
Kislyak O., Leont'eva M.
|
| 卷 13, 编号 4 (2016) |
The patients of high cardiovascular risk of healthy: unrecognized metabolic syndrome |
(Rus)
|
|
Blinova N., Zhernakova Y., Chazova I., Oshchepkova E.
|
| 卷 17, 编号 4 (2020) |
Primary hyperaldosteronism as a possible cause of resistant arterial hypertension |
(Rus)
|
|
Chikhladze N.
|
| 卷 7, 编号 4 (2010) |
Pervoe pokolenie sartanov: est' li perspektivy? |
|
|
Chazova I., Ratova L.
|
| 卷 7, 编号 4 (2010) |
Pervye itogi rossiyskogo issledovaniya STRATEGIYa A (roSsiyskaya mnogotsentrovaya programma po otsenke effekTivnostinolipRela A forTe u patsientov s artErial'noy GIpertoniey vysokogo riska s nedostatochnym kontrolem arterial'nogo davleniYa) -na puti optimizatsii antigipertenzivnoy terapii u bol'nykh arterial'noy gipertoniey vysokogo riska. |
|
|
Chazova I., Ratova L., Martynyuk T.
|
| 卷 12, 编号 2 (2015) |
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension |
(Rus)
|
|
Chazova E., Martyniuk T.
|
| 卷 9, 编号 3 (2012) |
Pervye rezul'taty mezhdunarodnogo klinicheskogo issledovaniya GEMERA: dva terapevticheskikh rezhima dlya effektivnogo lecheniya patsientov s arterial'noy gipertenziey 1-2-y stepeni |
|
|
Chazova I., Martynyuk T.
|
| 卷 17, 编号 2 (2020) |
First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension |
(Rus)
|
|
Chazova I., Martynyuk T., Rodnenkov V., Gorieva B., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Haisheva L., Kameneva T.
|
| 卷 11, 编号 4 (2014) |
First results of the Russian database of international prospective observational registry variability of blood pressure in patients with hypertension |
(Rus)
|
|
Ostroumova O.
|
| 卷 1, 编号 2 (2004) |
Pervye rezul'taty Rossiyskoy programmy po izucheniyu effektivnosti primeneniya akarbozy u patsientov s narushennoy tolerantnost'yu k glyukoze i arterial'noy gipertoniey (APREL') |
|
|
Chazova I., Mychka V., Belenkov Y.
|
| 卷 12, 编号 3 (2015) |
The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension |
(Rus)
|
|
Dadacheva Z., Belevskaya A., Saidova M., Danilov N., Martyniuk T., Chazova I.
|
| 卷 8, 编号 2 (2011) |
Perinatal'nye iskhody u beremennykhs arterial'noy gipertoniey,korrigirovannoy bisoprololomi nifedipinom SR/GITS |
|
|
Stryuk R., Brytkova Y., Pavlova L., Nemirovskiy V.
|
| 卷 11, 编号 4 (2014) |
Perindopril - angiotensin-converting enzyme inhibitor is approved for usage |
(Rus)
|
|
Napalkov D.
|
| 卷 6, 编号 2 (2009) |
Perindopril in treatment of patients with arterial hypertension and high cardiovascular risk |
|
|
Недогода С., Nedogoda S.
|
| 卷 5, 编号 2 (2008) |
Perindopril v lechenii arterial'noy gipertenzii u patsientov gruppy vysokogo riska |
|
|
Nedogoda S.
|
| 卷 12, 编号 1 (2015) |
Treatment with perindopril in patients with arterial hypertension: improving compliance |
(Rus)
|
|
Anikin G., Minina E., Andreevskaya E.
|
| 卷 8, 编号 1 (2011) |
Perindopril i ego kombinatsiya s indapamidom kak osnova dlya differentsirovannogo i individualizirovannogo lecheniya arterial'noygipertenzii. |
|
|
Nedogoda S.
|
| 卷 8, 编号 2 (2011) |
Perindopril: dokazatel'naya bazai vozmozhnosti primeneniya |
|
|
Napalkov D., Zhilenko A.
|
| 卷 6, 编号 2 (2009) |
Perspectives of using angiotensin receptor antagonists |
|
|
Fomin V.
|
| 卷 13, 编号 1 (2016) |
Loop diuretics in the treatment of hypertension and edema syndrome |
(Rus)
|
|
Kirichenko A.
|
| 卷 7, 编号 4 (2010) |
Pis'mo v redaktsiyu zhurnala «Sistemnye gipertenzii» |
|
|
- -.
|
| 卷 15, 编号 4 (2018) |
Organoprotection with arterial hypertension 2-3 degrees |
(Rus)
|
|
Afonicheva I., Melnik M., Knyazeva S., Kazyulin A.
|
| 卷 11, 编号 3 (2014) |
Pleiotropic features of dihydropyridine calcium channel antagonists |
(Rus)
|
|
Anikin G.
|
| 卷 17, 编号 2 (2020) |
DOACs: life-changing technologies |
(Rus)
|
|
Panchenko E., Shakhnovich R., Ageev F., Komarov A.
|
| 卷 1, 编号 1 (2004) |
Povyshenie arterial'nogo davleniya i gipotenzivnaya terapiya pri insul'te |
|
|
Parfenov V.
|
| 卷 2, 编号 2 (2005) |
Podkhody k lecheniyu arterial'noy gipertonii v usloviyakh statsionara: korrektsiya arterial'nogo davleniya i sostoyanie kognitivnykh funktsiy |
|
|
Ostroumova O., Desnitskaya I.
|
| 卷 12, 编号 1 (2015) |
The rise of cardiac biomarkers due to planned PCI and 1-year prognosis in patients with stable coronary artery disease and arterial hypertension |
(Rus)
|
|
Mironova O.
|
| 卷 7, 编号 1 (2010) |
Pozitsii diuretikov pri lechenii khronicheskoy serdechnoy nedostatochnosti |
|
|
Tereshchenko S., Dzhaiani N., Gnidkina N.
|
| 卷 14, 编号 3 (2017) |
Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level |
(Rus)
|
|
Avalyan A., Kirillova M., Shitov V., Oshchepkova Y., Saidova M., Stenina M., Chazova I.
|
| 卷 17, 编号 3 (2020) |
Parameters of acute vasoreactivity testing after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension |
(Rus)
|
|
Yarovoy S., Chazova I., Matchin Y., Danilov N.
|
| 卷 11, 编号 1 (2014) |
Aldosterone synthase gene polymorphism in patients with hypertension combined ischemic heart disease with in various left ventricular mass |
(Rus)
|
|
Yahontov D., Derisheva D., Gulyaeva L.
|
| 卷 17, 编号 4 (2020) |
Polymorphism of genes-candidates of renin-angiotensin-aldosteronovy system (ACE, AGT, AGTR1) and effectiveness of treatment of arterial hypertension. Results of research in Mountain Shoria |
(Rus)
|
|
Mulerova T., Morozova N., Maksimov V., Ogarkov M.
|
| 卷 7, 编号 1 (2010) |
Porazhenie serdechno-sosudistoy sistemy na fone terapii lekarstvennymi sredstvami, vliyayushchimi na appetit i massu tela |
|
|
Chazova I., Il'ina E., Tereshchenko S.
|
| 卷 5, 编号 3 (2008) |
Postprandial'noe snizhenie arterial'nogo davleniya u patsientov s essentsial'noy arterial'noy gipertenziey: aktual'nye voprosy patogeneza i lecheniya |
|
|
Barsukov A., Vasil'eva I., Shustov S.
|
| 卷 11, 编号 3 (2014) |
Why occurrence of arterial hypertension with age becomes frequent? |
(Rus)
|
|
Poseliugina O., Poseliugina E., Al-Galban N.
|
| 卷 9, 编号 2 (2012) |
Prakticheskie aspekty diagnostiki serdechno-sosudistykh faktorov riska u lits s sakharnym diabetom tipa 1 i 2 |
|
|
Mamedov M., Buzurtanova M., Kovrigina M.
|
| 卷 11, 编号 1 (2014) |
Practical aspects of fixed combinations in the treatment of hypertension |
(Rus)
|
|
Ogarkov M., Baranova M., Skripchenko A.
|
| 卷 13, 编号 1 (2016) |
Predictors of progression of atrial fibrillation in patients with arterial hypertension |
(Rus)
|
|
Podzolkov V., Tarzimanova A.
|
| 卷 18, 编号 4 (2021) |
Predictors of cardiovascular complications in patients with arterial hypertension and comorbid pathology |
(Rus)
|
|
Murkamilov I., Fomin V., Yusupov F., Sabirov I.
|
| 卷 6, 编号 3 (2009) |
Prevention of cardiovascular events at patients with arterial hypertension at treatmentangiotensin-converting enzyme inhibitor. |
|
|
Kislyak O., Postnikova S.
|
| 卷 14, 编号 2 (2017) |
Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy? |
(Rus)
|
|
Martynyuk T., Chazova I.
|
| 卷 11, 编号 2 (2014) |
The benefits of candesartan usage in the treatment of arterial hypertension |
(Rus)
|
|
Ostroumova O., Bondarets O., Guseva T.
|
| 卷 15, 编号 4 (2018) |
Advantages of control over the course of hypertension disease with the fixed combination of amlodipine and perindoprilе arginin |
(Rus)
|
|
Alyokhina O., Chesnokova I.
|
| 卷 3, 编号 2 (2006) |
Pri vsem bogatstve vybora drugoy al'ternativy net Issledovanie ETNA Plyus (ETNA v zhizni vracha polikliniki) |
|
|
Chazova I., Ratova L.
|
| 卷 7, 编号 3 (2010) |
Priverzhennost' lecheniyu - odna iz klyuchevykh determinant effektivnosti antigipertenzivnoy terapii: vozmozhnosti kombinatsii irbesartana s gidrokhlorotiazidom |
|
|
Fomin V.
|
| 卷 17, 编号 4 (2020) |
PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases |
(Rus)
|
|
Mikhailova O., Elfimova E., Litvin A., Chazova I.
|
| 卷 10, 编号 3 (2013) |
Primenenie diuretikov u bol'nykh arterial'noy gipertoniey s metabolicheskimi narusheniyami |
|
|
Zhernakova Y., Chazova I.
|
| 卷 5, 编号 1 (2008) |
Primenenie diuretikov u patsientov s arterial'noy gipertoniey i metabolicheskimi narusheniyami |
|
|
Tkacheva O., Galyautdinova A.
|
| 401 - 500 的 734 信息 |
<< < 1 2 3 4 5 6 7 8 > >> |
